Carolina S. Schmaltz
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Compartment-specific inflammation in tuberculous lymphadenitis: a case-control study.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: March 11, 2026
Hospitalization and diabetes mellitus as predictors of unfavorable tuberculosis treatment outcomes.
Journal: BMC infectious diseases
Published: September 07, 2025
Isoniazid Monoresistance and Antituberculosis Treatment Outcome in Persons With Pulmonary Tuberculosis in Brazil.
Journal: Open forum infectious diseases
Published: August 04, 2023
Impact of adverse drug reactions on the outcomes of tuberculosis treatment.
Journal: PloS one
Published: May 27, 2022
Systematic review on efficacy of preventive measures for surgical site infection by multiple-drug resistant gram-negative bacilli.
Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
Published: May 17, 2022
A summary of the proceedings of a meeting on the treatment of latent tuberculosis infection in target populations in Brazil.
Journal: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Published: July 23, 2020
Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274.
Journal: Frontiers in immunology
Published: May 01, 2019
Cutaneous tuberculosis in Rio de Janeiro, Brazil: description of a series of 75 cases.
Journal: International journal of dermatology
Published: April 15, 2019
Hip and Knee Section, Pathogen Factors: Proceedings of International Consensus on Orthopedic Infections.
Journal: The Journal of arthroplasty
Published: October 23, 2018
Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
Journal: Memorias do Instituto Oswaldo Cruz
Published: August 31, 2018
Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial.
Journal: BioMed research international
Published: August 22, 2018
Last Updated: 09/26/2026